Bridging the endocrine disruptor assessment of biocidal non-active substances with UK and EU REACH screening and assessment

The guidance broadly corresponds with that developed by ECHA (the European Chemicals Agency) and incorporates GB requirements.

Applies to:

Great Britain, Northern Ireland

Published by:

HSE

Published:

October 2022

Last updated:

October 2022

Guidance publications

Details

This document proposes a way forward to bridge the assessment of endocrine disrupting (ED) properties of non-active substances (so-called ‘co-formulants’) in biocidal products with the integrated regulatory strategy under Regulation (EC) No 1907/2006 (REACH).

Related content

Biocidal Products Regulation (UK legislation website)

Explore this topic

Biocides applications: information, assessments and evaluation